EcoDrugPlus

Solute Carrier Family 6 Member 9

Ensembl ID : ENSTRUG00000024850
Gene Symbol: SLC6A9
3 Cross references
208 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSTRUG00000012590
Gene Symbol: SLC9A3
4 Cross references
234 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSTRUG00000020419
Gene Symbol: SSTR2
4 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSTRUG00000020361
Gene Symbol: SSTR2
1 Cross references
192 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSTRUG00000001261
Gene Symbol: SSTR4
3 Cross references
206 Possible Orthologues:

Somatostatin Receptor Type 5

Ensembl ID : ENSTRUG00000026010
Gene Symbol: LOC101061835
2 Cross references
183 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSTRUG00000015629
Gene Symbol: SPHK2
4 Cross references
200 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSTRUG00000009829
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSTRUG00000009800
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSTRUG00000006606
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Substance-P Receptor

Ensembl ID : ENSTRUG00000018617
Gene Symbol: LOC101072387
2 Cross references
193 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSTRUG00000009668
Gene Symbol: SNCA
4 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).